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Endograft thrombus lining has been reported in up to one and an acceptable risk for bleeding events, regardless of limb
ﬁfth of all endovascular abdominal aneurysm repair (EVAR)
patients.1 Concern regarding endograft thrombus lining is
substantiated by reports suggesting that this process may
ultimately culminate in limb or endograft occlusion.2 How-
ever, these conclusions need to be interpreted with caution
as they are supported by studies with potentially biased
retrospective data.
Endograft thrombus lining results from the complex inter-
action of several factors, including systemic hemorheological
factors, local hemodynamics and device related characteris-
tics. Smoking is a well recognized pro-thrombotic risk factor
that may result in greater blood viscosity and systemic
inﬂammation and consequently enhance thrombus deposi-
tion. Modiﬁcation of the local hemodynamics by stent graft
implantation has also been suggested to play a role, as
thrombus lining has been identiﬁed very early following
EVAR.3 The local changes in blood ﬂowmay result fromdevice
related characteristics such as device conﬁguration and
geometrical conformation. Aorto-uni-iliac stent graft conﬁg-
uration has been associated with the development of a plug
ﬂow due to the sharp diameter transition, which may lead to
thrombus deposits.4 Also, the occurrence of peripheral ﬂow
deceleration with re-circulating patterns has been found to
occur in devices with larger diameters,4 and also leads to
thrombus accumulation. Additionally, several fabrics are
currently employed in different stent graft designs, which are
known to differ regarding thrombogenicity. Regarding EVAR
stent grafts, higher odds of thrombus accumulation have been
identiﬁed in polyester covered devices2
Management of asymptomatic thrombus lining has yet to
be established. Although conservative treatment has
remained consensual among most authors,1 oral anti-
coagulation and relining with a new endograft are alternative
options. In local experience endograft limb lining with
thrombus is most frequently the extension of the main body
thrombus lining. Moreover, despite a progressive build up of
in-graft thrombus found in most patients during follow up, it
is rarely associated with thromboembolic events (data
accepted for publication). Furthermore,most cases of limb or
device occlusion were found not to be preceded by limb
thrombus lining. Indeed uncorrected kinking, stenosis or
outﬂow limitations have been found to be the most common
causes of these events. In local practice, lifelong oral anti-
coagulation is reserved for patients with thromboembolism1078-5884/$ e see front matter  2015 European Society for Vascular
Surgery. Published by Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2015.01.020thrombus lining. Additionally, endograft relining with a less
thrombogenic device is considered if stent graft thrombus
deposits are thought to be the embolic source. In these cases,
oral anticoagulation may be discontinued if no further in-
graft thrombus develops subsequently.
In conclusion, more evidence is required to clarify the role
of asymptomatic limb thrombus lining in the development of
device related thromboembolic events. In patients with limb
kinking, stenosis, or outﬂow limitations, pre-emptive treat-
ment is warranted to avoid device related thrombosis. Close
observation coupled with a computerized tomography angi-
ography based surveillance regimen is appropriate for the
surveillance of patients with asymptomatic thrombus lining
of EVAR stent graft limbs during the ﬁrst post-operative year.
If no limb or outﬂow abnormalities have been identiﬁed, a
standard follow up regimen may be followed.REFERENCES
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